A new experimental drug shows promise for severe fatty liver disease. This compound targets the gut, not the liver directly. It repairs a d...

South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...

Bryan Johnson autoimmune disease: Anti-aging personality Bryan Johnson's recent revelation of autoimmune disease has ignited public interes...

After helping families finance critical treatments through Ketto, Kunal Kapoor is now focused on preventing those medical emergencies befor...

Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...

Snoring, often dismissed as a mere annoyance, can signal underlying health issues like sleep apnea. The sound arises from obstructed breath...

New research has revealed that deep sleep isn't just for rest; it actively regulates growth hormone, crucial for muscle repair, bone streng...

Yoga offers significant benefits for male fertility. A 12-week yoga program improved sperm quality and reduced oxidative stress and DNA dam...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...